TrialHealth technology assessment (Winchester, England)2025

Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT.

F D Richard Hobbs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.